News

The recommendation comes just weeks after the US Food and Drug Administration (FDA) approved the drug for use. Lenacapavir trials were conducted in Uganda and South Africa and demonstrated 100% ...
A new injectable drug known as lenacapavir could change how millions of people across the world and Africa in particular access HIV protective drugs, which historically have hard to come by. Presented ...
Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...
However, despite the Senate's decision to protect Pepfar from President Trump's proposed $400 million (Sh51.6 billion) ...
A decade ago, the global community established the goal to end AIDS as a public health threat by 2030 through reducing new HIV infections and AIDS-related deaths by 90% from 2010 levels.1 Progress has ...
Integrating people-centered HIV care with primary health care is essential to improving access, equity and health outcomes, but doing so successfully requires coordinated policies, digital ...
The U.S. Senate has opened debate on a $9 billion rescission bill to claw back foreign aid and other funding not aligned with ...
The International AIDS Society (IAS) has praised a bipartisan effort by the United States Senate to shield the President’s ...
An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
Zackie Achmat, once at the center of South Africa’s push for lifesaving H.I.V. treatment, has come out of retirement as U.S.
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...